SCHEMBL22192129

SCHEMBL22192129

CC/C(=C\C=C\c1ccccc1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 3/20 0.47
MAOB P27338 3/20 0.46
POLB P06746 1/20 0.45
TRPA1 O75762 2/20 0.41
ALOX5 P09917 1/20 0.41
MAPK1 P28482 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
HPGD P15428 1/20 0.40
PLIN1 O60240 1/20 0.40
BCHE P06276 1/20 0.40
MAPT P10636 1/20 0.40
TNFRSF1A P19438 1/20 0.40
ACHE P22303 1/20 0.40
RECQL P46063 1/20 0.40
PLIN5 Q00G26 1/20 0.40
CYP1B1 Q16678 1/20 0.40
ABHD5 Q8WTS1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5101844 1.00 LMNA (0.48) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL11708948 0.90 ALDH1A1 (0.49) LMNAALDH1A1KDM4EPOLBMAPK1
SCHEMBL13759947 0.87 LMNA (0.42) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL2380962 0.83 KDM4E (0.48) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL1507331 0.81 MAOB (0.46) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL369667 0.81 LMNA (0.44) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL28023700 0.80 LMNA (0.43) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL18760121 0.77 LMNA (0.42) LMNAALDH1A1KDM4EMAOBPOLB
SCHEMBL7912475 0.76 ESR1 (0.62) ESR1ESR2MEN1KMT2AMTNR1A
SCHEMBL1226484 0.76 ESR1 (0.62) ESR1ESR2MEN1KMT2AMTNR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10707423-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10707423-B2 Organic electroluminescent materials and devices OCIAD1, OXA1L, SLCO2B1 LMNA 2315/4885ALDH1A1 1137/4885KDM4E 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.